Skip to main content

Table 3 Median changes in tumor size and density according to RECIST 1.1 and the Choi criteria in evaluable patients (%)

From: Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?

Parameter

RECIST 1.1

Choi criteria

Size

Density

Size

Density

PR

−43.4

−17.8

−24.9

−16.8

SD

3.5

−5.8

3.8

−5.0

PD

21.0

1.2

18.2

3.2

Z value

13.888

4.256

13.263

6.352

P value

0.001

0.119

0.001

0.042